{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:24:01Z","timestamp":1789986241644,"version":"4.0.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41401-026-01869-8","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T02:31:39Z","timestamp":1783391499000},"page":"2761-2776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners"],"prefix":"10.1038","volume":"47","author":[{"given":"Chen-chen","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-zhou","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-yuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-zheng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-zhan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-tao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-jun","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-kang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,7]]},"reference":[{"key":"1869_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2022.114668","volume":"243","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang J, Wang J, Chen H, Ouyang L, Wang Y. Targeting GRK2 and GRK5 for treating chronic degenerative diseases: advances and future perspectives. Eur J Med Chem. 2022;243:114668.","journal-title":"Eur J Med Chem"},{"key":"1869_CR2","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00726-020-02864-x","volume":"52","author":"JH Kang","year":"2020","unstructured":"Kang JH, Toita R, Kawano T, Murata M, Asai D. Design of substrates and inhibitors of G protein-coupled receptor kinase 2 (GRK2) based on its phosphorylation reaction. Amino Acids. 2020;52:863\u201370.","journal-title":"Amino Acids"},{"key":"1869_CR3","doi-asserted-by":"publisher","first-page":"53643","DOI":"10.1074\/jbc.M401438200","volume":"279","author":"PW Day","year":"2004","unstructured":"Day PW, Tesmer JJ, Sterne-Marr R, Freeman LC, Benovic JL, Wedegaertner PB. Characterization of the GRK2 binding site of Galphaq. J Biol Chem. 2004;279:53643\u201352.","journal-title":"J Biol Chem"},{"key":"1869_CR4","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1118890","volume":"310","author":"VM Tesmer","year":"2005","unstructured":"Tesmer VM, Kawano T, Shankaranarayanan A, Kozasa T, Tesmer JJ. Snapshot of activated G proteins at the membrane: the Galphaq-GRK2-Gbetagamma complex. Science. 2005;310:1686\u201390.","journal-title":"Science"},{"key":"1869_CR5","doi-asserted-by":"publisher","first-page":"17206","DOI":"10.1074\/jbc.M809544200","volume":"284","author":"CC Huang","year":"2009","unstructured":"Huang CC, Yoshino-Koh K, Tesmer JJG. A surface of the kinase domain critical for the allosteric activation of G protein-coupled receptor kinases. J Biol Chem. 2009;284:17206\u201315.","journal-title":"J Biol Chem"},{"key":"1869_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ceb.2013.10.009","volume":"27","author":"KT Homan","year":"2014","unstructured":"Homan KT, Tesmer JJ. Structural insights into G protein-coupled receptor kinase function. Curr Opin Cell Biol. 2014;27:25\u201331.","journal-title":"Curr Opin Cell Biol"},{"key":"1869_CR7","doi-asserted-by":"publisher","first-page":"9277","DOI":"10.1021\/acs.jmedchem.5b01939","volume":"59","author":"M Guccione","year":"2016","unstructured":"Guccione M, Ettari R, Taliani S, Da Settimo F, Zappal\u00e0 M, Grasso S. G-protein-coupled receptor kinase 2 (GRK2) inhibitors: current trends and future perspectives. J Med Chem. 2016;59:9277\u201394.","journal-title":"J Med Chem"},{"key":"1869_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ceb.2013.10.005","volume":"27","author":"P Penela","year":"2014","unstructured":"Penela P, Nogu\u00e9s L, Mayor F Jr. Role of G protein-coupled receptor kinases in cell migration. Curr Opin Cell Biol. 2014;27:10\u201317.","journal-title":"Curr Opin Cell Biol"},{"key":"1869_CR9","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1159\/000495329","volume":"51","author":"C Han","year":"2018","unstructured":"Han C, Li Y, Wang Y, Cui D, Luo T, Zhang Y, et al. Development of inflammatory immune response-related drugs based on G protein-coupled receptor kinase 2. Cell Physiol Biochem. 2018;51:729\u201345.","journal-title":"Cell Physiol Biochem"},{"key":"1869_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fcvm.2016.00048","volume":"3","author":"D Sorriento","year":"2016","unstructured":"Sorriento D, Ciccarelli M, Cipolletta E, Trimarco B, Iaccarino G. \u201cFreeze, Don\u2019t Move\u201d: how to arrest a suspect in heart failure - a review on available GRK2 inhibitors. Front Cardiovasc Med. 2016;3:48.","journal-title":"Front Cardiovasc Med"},{"key":"1869_CR11","doi-asserted-by":"publisher","first-page":"9026","DOI":"10.1016\/S0021-9258(18)48041-6","volume":"262","author":"JL Benovic","year":"1987","unstructured":"Benovic JL, Mayor F Jr., Staniszewski C, Lefkowitz RJ, Caron MG. Purification and characterization of the beta-adrenergic receptor kinase. J Biol Chem. 1987;262:9026\u201332.","journal-title":"J Biol Chem"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/0014-5793(91)80568-N","volume":"283","author":"JL Benovic","year":"1991","unstructured":"Benovic JL, Stone WC, Huebner K, Croce C, Caron MG, Lefkowitz RJ. cDNA cloning and chromosomal localization of the human beta-adrenergic receptor kinase. FEBS Lett. 1991;283:122\u20136.","journal-title":"FEBS Lett"},{"key":"1869_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1126\/science.2552582","volume":"246","author":"JL Benovic","year":"1989","unstructured":"Benovic JL, DeBlasi A, Stone WC, Caron MG, Lefkowitz RJ. Beta-adrenergic receptor kinase: primary structure delineates a multigene family. Science. 1989;246:235\u201340.","journal-title":"Science"},{"key":"1869_CR14","doi-asserted-by":"publisher","first-page":"7325","DOI":"10.1021\/bi900408g","volume":"48","author":"CS Pao","year":"2009","unstructured":"Pao CS, Barker BL, Benovic JL. Role of the amino terminus of G protein-coupled receptor kinase 2 in receptor phosphorylation. Biochemistry. 2009;48:7325\u201333.","journal-title":"Biochemistry"},{"key":"1869_CR15","doi-asserted-by":"crossref","unstructured":"Kozasa T. The structure of GRK2-G beta gamma complex: intimate association of G-protein signaling modules. Trends Pharmacol Sci. 2004;25:61\u20133.","DOI":"10.1016\/j.tips.2003.12.006"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1877-1173(09)86004-3","volume":"86","author":"JJ Tesmer","year":"2009","unstructured":"Tesmer JJ. Structure and function of regulator of G protein signaling homology domains. Prog Mol Biol Transl Sci. 2009;86:75\u2013113.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"1869_CR17","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1021\/cb5003976","volume":"10","author":"KT Homan","year":"2015","unstructured":"Homan KT, Tesmer JJ. Molecular basis for small molecule inhibition of G protein-coupled receptor kinases. ACS Chem Biol. 2015;10:246\u201356.","journal-title":"ACS Chem Biol"},{"key":"1869_CR18","doi-asserted-by":"publisher","first-page":"20629","DOI":"10.1074\/jbc.M115.647297","volume":"290","author":"KE Komolov","year":"2015","unstructured":"Komolov KE, Bhardwaj A, Benovic JL. Atomic structure of GRK5 reveals distinct structural features novel for G protein-coupled receptor kinases. J Biol Chem. 2015;290:20629\u201347.","journal-title":"J Biol Chem"},{"key":"1869_CR19","doi-asserted-by":"publisher","first-page":"17000","DOI":"10.1074\/jbc.270.28.17000","volume":"270","author":"K Touhara","year":"1995","unstructured":"Touhara K, Koch WJ, Hawes BE, Lefkowitz RJ. Mutational analysis of the pleckstrin homology domain of the beta-adrenergic receptor kinase. Differential effects on G beta gamma and phosphatidylinositol 4,5-bisphosphate binding. J Biol Chem. 1995;270:17000\u20135.","journal-title":"J Biol Chem"},{"key":"1869_CR20","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1021\/acs.biochem.6b00354","volume":"55","author":"P Yang","year":"2016","unstructured":"Yang P, Homan KT, Li Y, Cruz-Rodr\u00edguez O, Tesmer JJ, Chen Z. Effect of lipid composition on the membrane orientation of the G protein-coupled receptor kinase 2-G\u03b21\u03b32 complex. Biochemistry. 2016;55:2841\u20138.","journal-title":"Biochemistry"},{"key":"1869_CR21","doi-asserted-by":"publisher","first-page":"6050","DOI":"10.1074\/jbc.M208787200","volume":"278","author":"R Sterne-Marr","year":"2003","unstructured":"Sterne-Marr R, Tesmer JJ, Day PW, Stracquatanio RP, Cilente JA, O\u2019Connor KE, et al. G protein-coupled receptor Kinase 2\/G alpha q\/11 interaction. A novel surface on a regulator of G protein signaling homology domain for binding G alpha subunits. J Biol Chem. 2003;278:6050\u20138.","journal-title":"J Biol Chem"},{"key":"1869_CR22","doi-asserted-by":"crossref","unstructured":"Fl\u00f6ser A, Becker K, Kostenis E, K\u00f6nig G, Krasel C, Kolb P, et al. Disentangling bias between G(q), GRK2, and arrestin3 recruitment to the M3 muscarinic acetylcholine receptor. Elife. 2021;10:e58442.","DOI":"10.7554\/eLife.58442"},{"key":"1869_CR23","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1073\/pnas.041604898","volume":"98","author":"LM Luttrell","year":"2001","unstructured":"Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci USA. 2001;98:2449\u201354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1869_CR24","doi-asserted-by":"crossref","unstructured":"Sallese M, Mariggi\u00f2 S, D\u2019Urbano E, Iacovelli L, De Blasi A. Selective regulation of Gq signaling by G protein-coupled receptor kinase 2: direct interaction of kinase N terminus with activated galphaq. Mol Pharmacol. 2000;57:826\u201331.","DOI":"10.1124\/mol.57.4.826"},{"key":"1869_CR25","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/1568005310101020139","volume":"1","author":"J Theilade","year":"2001","unstructured":"Theilade J, Hauns\u00f8 S, Sheikh SP. G protein-coupled receptor kinase 2\u2013a feedback regulator of Gq pathway signalling. Curr Drug Targets Immune Endocr Metab Disord. 2001;1:139\u201351.","journal-title":"Curr Drug Targets Immune Endocr Metab Disord"},{"key":"1869_CR26","doi-asserted-by":"publisher","first-page":"18273","DOI":"10.1074\/jbc.272.29.18273","volume":"272","author":"AN Pronin","year":"1997","unstructured":"Pronin AN, Satpaev DK, Slepak VZ, Benovic JL. Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J Biol Chem. 1997;272:18273\u201380.","journal-title":"J Biol Chem"},{"key":"1869_CR27","doi-asserted-by":"publisher","first-page":"13748","DOI":"10.1074\/jbc.M110.109272","volume":"285","author":"R Malhotra","year":"2010","unstructured":"Malhotra R, D\u2019Souza KM, Staron ML, Birukov KG, Bodi I, Akhter SA. G alpha(q)-mediated activation of GRK2 by mechanical stretch in cardiac myocytes: the role of protein kinase C. J Biol Chem. 2010;285:13748\u201360.","journal-title":"J Biol Chem"},{"key":"1869_CR28","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.cellsig.2006.03.004","volume":"18","author":"S Mariggi\u00f2","year":"2006","unstructured":"Mariggi\u00f2 S, Garc\u00eda-Hoz C, Sarnago S, De Blasi A, Mayor F Jr., Ribas C. Tyrosine phosphorylation of G-protein-coupled-receptor kinase 2 (GRK2) by c-Src modulates its interaction with Galphaq. Cell Signal. 2006;18:2004\u201312.","journal-title":"Cell Signal"},{"key":"1869_CR29","doi-asserted-by":"publisher","first-page":"8762","DOI":"10.1074\/jbc.M117.776799","volume":"292","author":"AD Brackley","year":"2017","unstructured":"Brackley AD, Sarrami S, Gomez R, Guerrero KA, Jeske NA. Identification of a signaling cascade that maintains constitutive \u03b4-opioid receptor incompetence in peripheral sensory neurons. J Biol Chem. 2017;292:8762\u201372.","journal-title":"J Biol Chem"},{"key":"1869_CR30","doi-asserted-by":"publisher","first-page":"15192","DOI":"10.1074\/jbc.M009130200","volume":"276","author":"M Cong","year":"2001","unstructured":"Cong M, Perry SJ, Lin FT, Fraser ID, Hu LA, Chen W, et al. Regulation of membrane targeting of the G protein-coupled receptor kinase 2 by protein kinase A and its anchoring protein AKAP79. J Biol Chem. 2001;276:15192\u20139.","journal-title":"J Biol Chem"},{"key":"1869_CR31","doi-asserted-by":"crossref","unstructured":"Xu R, Gopireddy RR, Wu Y, Wu L, Tao X, Shao J, et al. Hyperinsulinemia promotes heterologous desensitization of \u03b22 adrenergic receptor in airway smooth muscle in obesity. FASEB J. 2020;34:3996\u20134008.","DOI":"10.1096\/fj.201800688RR"},{"key":"1869_CR32","doi-asserted-by":"publisher","first-page":"34531","DOI":"10.1074\/jbc.274.49.34531","volume":"274","author":"JA Pitcher","year":"1999","unstructured":"Pitcher JA, Tesmer JJ, Freeman JL, Capel WD, Stone WC, Lefkowitz RJ. Feedback inhibition of G protein-coupled receptor kinase 2 (GRK2) activity by extracellular signal-regulated kinases. J Biol Chem. 1999;274:34531\u20134.","journal-title":"J Biol Chem"},{"key":"1869_CR33","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016056","volume":"296","author":"D Kim","year":"2021","unstructured":"Kim D, Casta\u00f1o M, Lujan LK, Woo JA, Liggett SB. The short third intracellular loop and cytoplasmic tail of bitter taste receptors provide functionally relevant GRK phosphorylation sites in TAS2R14. J Biol Chem. 2021;296:100216.","journal-title":"J Biol Chem"},{"key":"1869_CR34","doi-asserted-by":"crossref","unstructured":"Echeverr\u00eda E, Ripoll S, Fabi\u00e1n L, Shayo C, Monczor F, Fern\u00e1ndez NC. Novel inhibitors of phosphorylation independent activity of GRK2 modulate cAMP signaling. Pharmacol Res Perspect. 2022;10:e00913.","DOI":"10.1002\/prp2.913"},{"key":"1869_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq3363","volume":"8","author":"G Xiang","year":"2022","unstructured":"Xiang G, Acosta-Ruiz A, Radoux-Mergault A, Kristt M, Kim J, Moon JD, et al. Control of G\u03b1(q) signaling dynamics and GPCR cross-talk by GRKs. Sci Adv. 2022;8:eabq3363.","journal-title":"Sci Adv"},{"key":"1869_CR36","doi-asserted-by":"publisher","first-page":"23444","DOI":"10.1074\/jbc.M109.000778","volume":"284","author":"FM Ribeiro","year":"2009","unstructured":"Ribeiro FM, Ferreira LT, Paquet M, Cregan T, Ding Q, Gros R, et al. Phosphorylation-independent regulation of metabotropic glutamate receptor 5 desensitization and internalization by G protein-coupled receptor kinase 2 in neurons. J Biol Chem. 2009;284:23444\u201353.","journal-title":"J Biol Chem"},{"key":"1869_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1134\/S0026893313010160","volume":"47","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Xue L, Guo H, Li Y, Ding H, Huang S. Phosphorylation-independent desensitization of metabotropic glutamate receptor 5 by G protein-coupled receptor kinase 2 in HEK 293 cells. Mol Biol. 2013;47:137\u201346.","journal-title":"Mol Biol"},{"key":"1869_CR38","doi-asserted-by":"publisher","first-page":"28697","DOI":"10.1074\/jbc.M111.269613","volume":"286","author":"N Fernandez","year":"2011","unstructured":"Fernandez N, Gottardo FL, Alonso MN, Monczor F, Shayo C, Davio C. Roles of phosphorylation-dependent and -independent mechanisms in the regulation of histamine H2 receptor by G protein-coupled receptor kinase 2. J Biol Chem. 2011;286:28697\u2013706.","journal-title":"J Biol Chem"},{"key":"1869_CR39","doi-asserted-by":"publisher","first-page":"32138","DOI":"10.1074\/jbc.M113.461566","volume":"288","author":"F G\u00e4rtner","year":"2013","unstructured":"G\u00e4rtner F, Seidel T, Schulz U, Gummert J, Milting H. Desensitization and internalization of endothelin receptor A: impact of G protein-coupled receptor kinase 2 (GRK2)-mediated phosphorylation. J Biol Chem. 2013;288:32138\u201348.","journal-title":"J Biol Chem"},{"key":"1869_CR40","doi-asserted-by":"publisher","first-page":"7055","DOI":"10.1073\/pnas.1118359109","volume":"109","author":"H Zheng","year":"2012","unstructured":"Zheng H, Worrall C, Shen H, Issad T, Seregard S, Girnita A, et al. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor. Proc Natl Acad Sci USA. 2012;109:7055\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1869_CR41","doi-asserted-by":"crossref","unstructured":"Kundu D, Min X, Wang S, Peng L, Tian X, Wang M, et al. Transactivation of the EGF receptor as a novel desensitization mechanism for G protein-coupled receptors, illustrated by dopamine D2-like and \u03b22 adrenergic receptors. Cell Mol Biol Lett. 2024;29:132.","DOI":"10.1186\/s11658-024-00652-z"},{"key":"1869_CR42","doi-asserted-by":"publisher","first-page":"31027","DOI":"10.1074\/jbc.M501473200","volume":"280","author":"JH Wu","year":"2005","unstructured":"Wu JH, Goswami R, Kim LK, Miller WE, Peppel K, Freedman NJ. The platelet-derived growth factor receptor-beta phosphorylates and activates G protein-coupled receptor kinase-2. A mechanism for feedback inhibition. J Biol Chem. 2005;280:31027\u201335.","journal-title":"J Biol Chem"},{"key":"1869_CR43","doi-asserted-by":"publisher","first-page":"19259","DOI":"10.1074\/jbc.M111.239772","volume":"286","author":"IH Lee","year":"2011","unstructured":"Lee IH, Song SH, Campbell CR, Kumar S, Cook DI, Dinudom A. Regulation of the epithelial Na+ channel by the RH domain of G protein-coupled receptor kinase, GRK2, and Galphaq\/11. J Biol Chem. 2011;286:19259\u201369.","journal-title":"J Biol Chem"},{"key":"1869_CR44","doi-asserted-by":"publisher","first-page":"e3002685","DOI":"10.1371\/journal.pbio.3002685","volume":"22","author":"MF Walker","year":"2024","unstructured":"Walker MF, Zhang J, Steiner W, Ku PI, Zhu JF, Michaelson Z, et al. GRK2 kinases in the primary cilium initiate SMOOTHENED-PKA signaling in the Hedgehog cascade. PLoS Biol. 2024;22:e3002685.","journal-title":"PLoS Biol"},{"key":"1869_CR45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yjmcc.2018.08.025","volume":"123","author":"J Pfleger","year":"2018","unstructured":"Pfleger J, Gross P, Johnson J, Carter RL, Gao E, Tilley DG, et al. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart. J Mol Cell Cardiol. 2018;123:108\u201317.","journal-title":"J Mol Cell Cardiol"},{"key":"1869_CR46","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.bbrc.2007.05.134","volume":"359","author":"A Sanchez-Perez","year":"2007","unstructured":"Sanchez-Perez A, Kumar S, Cook DI. GRK2 interacts with and phosphorylates Nedd4 and Nedd4-2. Biochem Biophys Res Commun. 2007;359:611\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"1869_CR47","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/ATVBAHA.125.322645","volume":"45","author":"CH Kong","year":"2025","unstructured":"Kong CH, Sun Y, Wu LD, Zhou WY, Wang DC, Jiang ZH, et al. GRK2 orchestrates VSMC phenotypic modulation via DNMT1-mediated DNA methylation reprogramming. Arterioscler Thromb Vasc Biol. 2025;45:1818\u201334.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1869_CR48","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/BJ20090908","volume":"425","author":"S Patial","year":"2009","unstructured":"Patial S, Luo J, Porter KJ, Benovic JL, Parameswaran N. G-protein-coupled-receptor kinases mediate TNF\u03b1-induced NF\u03baB signalling via direct interaction with and phosphorylation of I\u03baB\u03b1. Biochem J. 2009;425:169\u201378.","journal-title":"Biochem J"},{"key":"1869_CR49","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.cub.2018.07.033","volume":"28","author":"S Peregrin","year":"2018","unstructured":"Peregrin S, Jurado-Pueyo M, Campos PM, Sanz-Moreno V, Ruiz-Gomez A, Crespo P, et al. Phosphorylation of p38 by GRK2 at the docking groove unveils a novel mechanism for inactivating p38MAPK. Curr Biol. 2018;28:2513.","journal-title":"Curr Biol"},{"key":"1869_CR50","doi-asserted-by":"crossref","unstructured":"Yang XZ, Zhang WK, Zhu ZQ, Zhao W, Luo LL, Wang LP, et al. GRK2-mediated phosphorylation and de-succinylation of PKM2 reduce macrophage glycolysis in rheumatoid arthritis. Acta Pharmacol Sin. 2025;46:2693\u2013706.","DOI":"10.1038\/s41401-025-01582-y"},{"key":"1869_CR51","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/emboj.2011.466","volume":"31","author":"V Lafarga","year":"2012","unstructured":"Lafarga V, Aymerich I, Tapia O, Mayor F Jr., Penela P. A novel GRK2\/HDAC6 interaction modulates cell spreading and motility. EMBO J. 2012;31:856\u201369.","journal-title":"EMBO J"},{"key":"1869_CR52","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ebiom.2016.09.030","volume":"13","author":"L Nogu\u00e9s","year":"2016","unstructured":"Nogu\u00e9s L, Reglero C, Rivas V, Salcedo A, Lafarga V, Neves M, et al. G protein-coupled receptor kinase 2 (GRK2) promotes breast tumorigenesis through a HDAC6-Pin1 axis. EBioMedicine. 2016;13:132\u201345.","journal-title":"EBioMedicine"},{"key":"1869_CR53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.3390\/cancers12051216","volume":"12","author":"C Reglero","year":"2020","unstructured":"Reglero C, Lafarga V, Rivas V, Albitre \u00c1, Ramos P, Berciano SR, et al. GRK2-dependent HuR phosphorylation regulates HIF1\u03b1 activation under hypoxia or adrenergic stress. Cancers. 2020;12:1216.","journal-title":"Cancers"},{"key":"1869_CR54","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.3390\/cancers12123530","volume":"12","author":"J Gambardella","year":"2020","unstructured":"Gambardella J, Fiordelisi A, Santulli G, Ciccarelli M, Cerasuolo FA, Sala M, et al. Exploiting GRK2 inhibition as a therapeutic option in experimental cancer treatment: role of p53-induced mitochondrial apoptosis. Cancers. 2020;12:3530.","journal-title":"Cancers"},{"key":"1869_CR55","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/ijc.32838","volume":"147","author":"J Palacios-Garc\u00eda","year":"2020","unstructured":"Palacios-Garc\u00eda J, Sanz-Flores M, Asensio A, Alvarado R, Rojo-Berciano S, Stamatakis K, et al. G-protein-coupled receptor kinase 2 safeguards epithelial phenotype in head and neck squamous cell carcinomas. Int J Cancer. 2020;147:218\u201329.","journal-title":"Int J Cancer"},{"key":"1869_CR56","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1210\/me.2009-0084","volume":"23","author":"L Wang","year":"2009","unstructured":"Wang L, Gesty-Palmer D, Fields TA, Spurney RF. Inhibition of WNT signaling by G protein-coupled receptor (GPCR) kinase 2 (GRK2). Mol Endocrinol. 2009;23:1455\u201365.","journal-title":"Mol Endocrinol"},{"key":"1869_CR57","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/cells10040729","volume":"10","author":"C Reglero","year":"2021","unstructured":"Reglero C, Ortiz Del Castillo B, Rivas V, Mayor F Jr, Penela P. Mdm2-mediated downmodulation of GRK2 restricts centrosome separation for proper chromosome congression. Cells. 2021;10:729.","journal-title":"Cells"},{"key":"1869_CR58","doi-asserted-by":"publisher","first-page":"C63","DOI":"10.1152\/ajpcell.00347.2021","volume":"322","author":"Y Li","year":"2022","unstructured":"Li Y, Sun Y, Wu N, Ma H. GRK2 promotes activation of lung fibroblast cells and contributes to pathogenesis of pulmonary fibrosis through increasing Smad3 expression. Am J Physiol Cell Physiol. 2022;322:C63\u2013c72.","journal-title":"Am J Physiol Cell Physiol"},{"key":"1869_CR59","doi-asserted-by":"crossref","unstructured":"Cannavo A, Marzano F, Elia A, Liccardo D, Bencivenga L, Gambino G, et al. Aldosterone jeopardizes myocardial insulin and \u03b2-adrenergic receptor signaling via G protein-coupled receptor kinase 2. Front Pharmacol. 2019;10:888.","DOI":"10.3389\/fphar.2019.00888"},{"key":"1869_CR60","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1007\/s00125-018-4562-x","volume":"61","author":"X Qi","year":"2018","unstructured":"Qi X, Guo Y, Song Y, Yu C, Zhao L, Fang L, et al. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Diabetologia. 2018;61:1180\u201392.","journal-title":"Diabetologia"},{"key":"1869_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41420-018-0028-7","volume":"4","author":"A Franco","year":"2018","unstructured":"Franco A, Sorriento D, Gambardella J, Pacelli R, Prevete N, Procaccini C, et al. GRK2 moderates the acute mitochondrial damage to ionizing radiation exposure by promoting mitochondrial fission\/fusion. Cell Death Discov. 2018;4:25.","journal-title":"Cell Death Discov"},{"key":"1869_CR62","doi-asserted-by":"publisher","first-page":"31940","DOI":"10.1016\/S0021-9258(19)84108-X","volume":"281","author":"S Mangmool","year":"2006","unstructured":"Mangmool S, Haga T, Kobayashi H, Kim KM, Nakata H, Nishida M, et al. Clathrin required for phosphorylation and internalization of beta2-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2). J Biol Chem. 2006;281:31940\u20139.","journal-title":"J Biol Chem"},{"key":"1869_CR63","doi-asserted-by":"publisher","first-page":"8858","DOI":"10.1074\/jbc.274.13.8858","volume":"274","author":"CV Carman","year":"1999","unstructured":"Carman CV, Lisanti MP, Benovic JL. Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem. 1999;274:8858\u201364.","journal-title":"J Biol Chem"},{"key":"1869_CR64","doi-asserted-by":"publisher","first-page":"a34","DOI":"10.2741\/987","volume":"8","author":"S Ji","year":"2003","unstructured":"Ji S, Liu X, Li S, Shen L, Li F, Wang J, et al. PH domain of G protein-coupled receptor kinase-2 binds to protein kinase C (PKC) and negatively regulates activity of PKC kinase. Front Biosci. 2003;8:a34\u2013a39.","journal-title":"Front Biosci"},{"key":"1869_CR65","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41420-024-02143-8","volume":"10","author":"V Rivas","year":"2024","unstructured":"Rivas V, Gonz\u00e1lez-Mu\u00f1oz T, Albitre \u00c1, Lafarga V, Delgado-Ar\u00e9valo C, Mayor F Jr., et al. GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner. Cell Death Discov. 2024;10:385.","journal-title":"Cell Death Discov"},{"key":"1869_CR66","doi-asserted-by":"crossref","unstructured":"Jin C, Gao BB, Zhou WJ, Zhao BJ, Fang X, Yang CL, et al. Hydroxychloroquine attenuates autoimmune hepatitis by suppressing the interaction of GRK2 with PI3K in T lymphocytes. Front Pharmacol. 2022;13:972397.","DOI":"10.3389\/fphar.2022.972397"},{"key":"1869_CR67","doi-asserted-by":"crossref","unstructured":"Jiang Z, Kan J, Wang D, Lv Y, Kong C, Wu L, et al. Inhibition of GRK2 reduced doxorubicin-induced oxidative stress and apoptosis through upregulating ADH1. Toxicol Appl Pharmacol. 2025;497:117261.","DOI":"10.1016\/j.taap.2025.117261"},{"key":"1869_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/falgy.2021.656886","volume":"2","author":"AK Kammala","year":"2021","unstructured":"Kammala AK, Yang C, Panettieri RA, Das R, Subramanian H. G protein-coupled receptor kinase 2 (GRK2) regulates T cell response in a murine model of house dust mite-induced asthma. Front Allergy. 2021;2:656886.","journal-title":"Front Allergy"},{"key":"1869_CR69","doi-asserted-by":"crossref","unstructured":"Tai Y, Huang B, Guo PP, Wang Z, Zhou ZW, Wang MM, et al. TNF-\u03b1 impairs EP4 signaling through the association of TRAF2-GRK2 in primary fibroblast-like synoviocytes. Acta Pharmacol Sin. 2022;43:401\u201316.","DOI":"10.1038\/s41401-021-00654-z"},{"key":"1869_CR70","doi-asserted-by":"publisher","first-page":"10183","DOI":"10.1073\/pnas.0812105106","volume":"106","author":"X Jiang","year":"2009","unstructured":"Jiang X, Yang P, Ma L. Kinase activity-independent regulation of cyclin pathway by GRK2 is essential for zebrafish early development. Proc Natl Acad Sci USA. 2009;106:10183\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1869_CR71","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.apsb.2023.09.013","volume":"14","author":"X Yang","year":"2024","unstructured":"Yang X, Zhao Y, Wei Q, Zhu X, Wang L, Zhang W, et al. GRK2 inhibits Flt-1(+) macrophage infiltration and its proangiogenic properties in rheumatoid arthritis. Acta Pharm Sin B. 2024;14:241\u201355.","journal-title":"Acta Pharm Sin B"},{"key":"1869_CR72","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jcp.22384","volume":"226","author":"S Patial","year":"2011","unstructured":"Patial S, Saini Y, Parvataneni S, Appledorn DM, Dorn GW 2nd, Lapres JJ, et al. Myeloid-specific GPCR kinase-2 negatively regulates NF-\u03baB1p105-ERK pathway and limits endotoxemic shock in mice. J Cell Physiol. 2011;226:627\u201337.","journal-title":"J Cell Physiol"},{"key":"1869_CR73","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.apsb.2023.12.007","volume":"14","author":"P Guo","year":"2024","unstructured":"Guo P, Jiang J, Chu R, He F, Ge M, Fang R, et al. GRK2 mediated degradation of SAV1 initiates hyperplasia of fibroblast-like synoviocytes in rheumatoid arthritis. Acta Pharm Sin B. 2024;14:1222\u201340.","journal-title":"Acta Pharm Sin B"},{"key":"1869_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.111706","volume":"131","author":"T Tian","year":"2025","unstructured":"Tian T, Wei M, Guan Y, Rao L, Luo T, Han C, et al. Paeoniflorin-6\u2019-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis. Cell Signal. 2025;131:111706.","journal-title":"Cell Signal"},{"key":"1869_CR75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200504","volume":"218","author":"A Saveliev","year":"2021","unstructured":"Saveliev A, Bell SE, Turner M. Efficient homing of antibody-secreting cells to the bone marrow requires RNA-binding protein ZFP36L1. J Exp Med. 2021;218:e20200504.","journal-title":"J Exp Med"},{"key":"1869_CR76","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3892\/etm.2023.11975","volume":"25","author":"B Xiong","year":"2023","unstructured":"Xiong B, Chen L, Huang Y, Lu G, Chen C, Nong J, et al. ZBTB16 eases lipopolysaccharide\u2011elicited inflammation, apoptosis and degradation of extracellular matrix in chondrocytes during osteoarthritis by suppressing GRK2 transcription. Exp Ther Med. 2023;25:276.","journal-title":"Exp Ther Med"},{"key":"1869_CR77","doi-asserted-by":"publisher","first-page":"362","DOI":"10.31083\/j.fbl2910362","volume":"29","author":"S Wang","year":"2024","unstructured":"Wang S, Zhang C, Hu H, Xu J, Zhang J, Zhou W, et al. GRK2 protein mediates the ANRIL, a lncRNA, to affect the proliferation and apoptosis of Kasumi-1 cells. Front Biosci. 2024;29:362.","journal-title":"Front Biosci"},{"key":"1869_CR78","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1172\/JCI97040","volume":"130","author":"J Cheng","year":"2020","unstructured":"Cheng J, Klei LR, Hubel NE, Zhang M, Schairer R, Maurer LM, et al. GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. J Clin Invest. 2020;130:1036\u201351.","journal-title":"J Clin Invest"},{"key":"1869_CR79","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1042\/BCJ20170093","volume":"474","author":"MD Steury","year":"2017","unstructured":"Steury MD, Lucas PC, McCabe LR, Parameswaran N. G-protein-coupled receptor kinase-2 is a critical regulator of TNF\u03b1 signaling in colon epithelial cells. Biochem J. 2017;474:2301\u201313.","journal-title":"Biochem J"},{"key":"1869_CR80","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1016\/j.cellsig.2013.08.031","volume":"25","author":"JD Robinson","year":"2013","unstructured":"Robinson JD, Pitcher JA. G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade. Cell Signal. 2013;25:2831\u20139.","journal-title":"Cell Signal"},{"key":"1869_CR81","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s11010-020-03969-3","volume":"476","author":"JC Ammon","year":"2021","unstructured":"Ammon JC, Valls D, Eldemerdash M, Patel JR, Tran PD, Feng L, et al. G protein-coupled receptor kinase 2 modifies the cellular reaction to cisplatin through interactions with NADPH oxidase 4. Mol Cell Biochem. 2021;476:1505\u201316.","journal-title":"Mol Cell Biochem"},{"key":"1869_CR82","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2022.07.012","volume":"172","author":"J Fu","year":"2022","unstructured":"Fu J, Li L, Chen L, Su C, Feng X, Huang K, et al. PGE2 protects against heart failure through inhibiting TGF-\u03b21 synthesis in cardiomyocytes and crosstalk between TGF-\u03b21 and GRK2. J Mol Cell Cardiol. 2022;172:63\u201377.","journal-title":"J Mol Cell Cardiol"},{"key":"1869_CR83","first-page":"223","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wu Y, Zhou M, Wang P, Luo J, Rui Y. GRK2 deletion improves the function of skin flap following ischemia-reperfusion injury by regulating Drp1. Am J Transl Res. 2021;13:223\u201333.","journal-title":"Am J Transl Res"},{"key":"1869_CR84","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqaa229","volume":"162","author":"HS Carr","year":"2021","unstructured":"Carr HS, Chang JT, Frost JA. The PDZ domain protein SYNJ2BP regulates GRK-dependent sst2A phosphorylation and downstream MAPK signaling. Endocrinology. 2021;162:bqaa229.","journal-title":"Endocrinology"},{"key":"1869_CR85","doi-asserted-by":"publisher","DOI":"10.1530\/REP-23-0463","volume":"168","author":"D Zhou","year":"2024","unstructured":"Zhou D, Li XH, Lee SH, Kim JD, Lee GH, Sim JM, et al. GRK2 is critical for the cleavage of the porcine embryo by regulating HSP90 and the AKT pathway. Reproduction. 2024;168:e230463.","journal-title":"Reproduction"},{"key":"1869_CR86","doi-asserted-by":"publisher","first-page":"L93","DOI":"10.1152\/ajplung.00091.2017","volume":"314","author":"S Barreto Ortiz","year":"2018","unstructured":"Barreto Ortiz S, Hori D, Nomura Y, Yun X, Jiang H, Yong H, et al. Opsin 3 and 4 mediate light-induced pulmonary vasorelaxation that is potentiated by G protein-coupled receptor kinase 2 inhibition. Am J Physiol Lung Cell Mol Physiol. 2018;314:L93\u2013l106.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1869_CR87","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbamcr.2015.10.007","volume":"1863","author":"M Zheng","year":"2016","unstructured":"Zheng M, Zhang X, Guo S, Zhang X, Min C, Cheon SH, et al. Agonist-induced changes in RalA activities allows the prediction of the endocytosis of G protein-coupled receptors. Biochim Biophys Acta. 2016;1863:77\u201390.","journal-title":"Biochim Biophys Acta"},{"key":"1869_CR88","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1074\/jbc.M008773200","volume":"276","author":"C Krasel","year":"2001","unstructured":"Krasel C, Dammeier S, Winstel R, Brockmann J, Mischak H, Lohse MJ. Phosphorylation of GRK2 by protein kinase C abolishes its inhibition by calmodulin. J Biol Chem. 2001;276:1911\u20135.","journal-title":"J Biol Chem"},{"key":"1869_CR89","doi-asserted-by":"crossref","unstructured":"Sun N, Zhang X, Zhang X, Kim KM. The EGF receptor inhibits the signaling of dopamine D3 receptor through the phosphorylation of GRK2 on tyrosine residues. Biochem Biophys Res Commun. 2017;489:515\u201322.","DOI":"10.1016\/j.bbrc.2017.05.183"},{"key":"1869_CR90","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cell.2007.02.046","volume":"129","author":"EJ Whalen","year":"2007","unstructured":"Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, et al. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell. 2007;129:511\u201322.","journal-title":"Cell"},{"key":"1869_CR91","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.95998","volume":"2","author":"PY Jean-Charles","year":"2017","unstructured":"Jean-Charles PY, Yu SM, Abraham D, Kommaddi RP, Mao L, Strachan RT, et al. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of \u03b2-adrenergic receptor signaling. JCI insight. 2017;2:e95998.","journal-title":"JCI insight"},{"key":"1869_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.263","volume":"8","author":"F Zhang","year":"2017","unstructured":"Zhang F, Xiang S, Cao Y, Li M, Ma Q, Liang H, et al. EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway. Cell Death Dis. 2017;8:e2868.","journal-title":"Cell Death Dis"},{"key":"1869_CR93","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.canlet.2017.08.013","volume":"408","author":"ZQ Wang","year":"2017","unstructured":"Wang ZQ, He CY, Hu L, Shi HP, Li JF, Gu QL, et al. Long noncoding RNA UCA1 promotes tumour metastasis by inducing GRK2 degradation in gastric cancer. Cancer lett. 2017;408:10\u201321.","journal-title":"Cancer lett"},{"key":"1869_CR94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.cellsig.2017.07.004","volume":"41","author":"KE Komolov","year":"2018","unstructured":"Komolov KE, Benovic JL. G protein-coupled receptor kinases: past, present and future. Cell Signal. 2018;41:17\u201324.","journal-title":"Cell Signal"},{"key":"1869_CR95","doi-asserted-by":"publisher","first-page":"ra30","DOI":"10.1126\/scisignal.aae0549","volume":"9","author":"SM Schumacher","year":"2016","unstructured":"Schumacher SM, Gao E, Cohen M, Lieu M, Chuprun JK, Koch WJ. A peptide of the RGS domain of GRK2 binds and inhibits G\u03b1(q) to suppress pathological cardiac hypertrophy and dysfunction. Sci Signal. 2016;9:ra30.","journal-title":"Sci Signal"},{"key":"1869_CR96","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1016\/j.apsb.2025.10.026","volume":"15","author":"M Liu","year":"2025","unstructured":"Liu M, Svirskis D, Proft T, Loh J, Yin N, Li H, et al. Progress in peptide and protein therapeutics: challenges and strategies. Acta Pharm Sin B. 2025;15:6342\u201381.","journal-title":"Acta Pharm Sin B"},{"key":"1869_CR97","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.2174\/0929867323666160909155222","volume":"23","author":"J Rafferty","year":"2016","unstructured":"Rafferty J, Nagaraj H, McCloskey AP, Huwaitat R, Porter S, Albadr A, et al. Peptide therapeutics and the pharmaceutical industry: barriers encountered translating from the Laboratory to Patients. Curr Med Chem. 2016;23:4231\u201359.","journal-title":"Curr Med Chem"},{"key":"1869_CR98","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1126\/science.1120378","volume":"312","author":"TM Bonacci","year":"2006","unstructured":"Bonacci TM, Mathews JL, Yuan C, Lehmann DM, Malik S, Wu D, et al. Differential targeting of Gbetagamma-subunit signaling with small molecules. Science. 2006;312:443\u20136.","journal-title":"Science"},{"key":"1869_CR99","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.yjmcc.2010.08.014","volume":"50","author":"G Rengo","year":"2011","unstructured":"Rengo G, Lymperopoulos A, Leosco D, Koch WJ. GRK2 as a novel gene therapy target in heart failure. J Mol Cell Cardiol. 2011;50:785\u201392.","journal-title":"J Mol Cell Cardiol"},{"key":"1869_CR100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1161\/CIRCULATIONAHA.108.803999","volume":"119","author":"G Rengo","year":"2009","unstructured":"Rengo G, Lymperopoulos A, Zincarelli C, Donniacuo M, Soltys S, Rabinowitz JE, et al. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure. Circulation. 2009;119:89\u201398.","journal-title":"Circulation"},{"key":"1869_CR101","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/eurheartj\/ehr447","volume":"34","author":"PW Raake","year":"2013","unstructured":"Raake PW, Schlegel P, Ksienzyk J, Reinkober J, Barthelmes J, Schinkel S, et al. AAV6.\u03b2ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Eur Heart J. 2013;34:1437\u201347.","journal-title":"Eur Heart J"},{"key":"1869_CR102","doi-asserted-by":"crossref","unstructured":"Lehmann DM, Seneviratne AM, Smrcka AV. Small molecule disruption of G protein beta gamma subunit signaling inhibits neutrophil chemotaxis and inflammation. Mol Pharmacol. 2008;73:410\u20138.","DOI":"10.1124\/mol.107.041780"},{"key":"1869_CR103","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1161\/CIRCRESAHA.110.217075","volume":"107","author":"LM Casey","year":"2010","unstructured":"Casey LM, Pistner AR, Belmonte SL, Migdalovich D, Stolpnik O, Nwakanma FE, et al. Small molecule disruption of G beta gamma signaling inhibits the progression of heart failure. Circ Res. 2010;107:532\u20139.","journal-title":"Circ Res"},{"key":"1869_CR104","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.jacc.2014.02.587","volume":"63","author":"FA Kamal","year":"2014","unstructured":"Kamal FA, Mickelsen DM, Wegman KM, Travers JG, Moalem J, Hammes SR, et al. Simultaneous adrenal and cardiac G-protein-coupled receptor-G\u03b2\u03b3 inhibition halts heart failure progression. J Am Coll Cardiol. 2014;63:2549\u201357.","journal-title":"J Am Coll Cardiol"},{"key":"1869_CR105","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.3390\/ijms23147933","volume":"23","author":"V Karuppagounder","year":"2022","unstructured":"Karuppagounder V, Pinamont W, Yoshioka N, Elbarbary R, Kamal F. Early G\u03b2\u03b3-GRK2 inhibition ameliorates osteoarthritis development by simultaneous anti-inflammatory and chondroprotective effects. Int J Mol Sci. 2022;23:7933.","journal-title":"Int J Mol Sci"},{"key":"1869_CR106","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrd.2018.135","volume":"17","author":"AP Campbell","year":"2018","unstructured":"Campbell AP, Smrcka AV. Targeting G protein-coupled receptor signalling by blocking G proteins. Nat Rev Drug Discov. 2018;17:789\u2013803.","journal-title":"Nat Rev Drug Discov"},{"key":"1869_CR107","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.ejmech.2013.08.039","volume":"69","author":"A Carotenuto","year":"2013","unstructured":"Carotenuto A, Cipolletta E, Gomez-Monterrey I, Sala M, Vernieri E, Limatola A, et al. Design, synthesis and efficacy of novel G protein-coupled receptor kinase 2 inhibitors. Eur J Med Chem. 2013;69:384\u201392.","journal-title":"Eur J Med Chem"},{"key":"1869_CR108","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1007\/s00125-004-1444-1","volume":"47","author":"Y Anis","year":"2004","unstructured":"Anis Y, Leshem O, Reuveni H, Wexler I, Ben Sasson R, Yahalom B, et al. Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia. 2004;47:1232\u201344.","journal-title":"Diabetologia"},{"key":"1869_CR109","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1261\/rna.821908","volume":"14","author":"G Mayer","year":"2008","unstructured":"Mayer G, Wulffen B, Huber C, Brockmann J, Flicke B, Neumann L, et al. An RNA molecule that specifically inhibits G-protein-coupled receptor kinase 2 in vitro. RNA. 2008;14:524\u201334.","journal-title":"RNA"},{"key":"1869_CR110","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.str.2012.05.002","volume":"20","author":"VM Tesmer","year":"2012","unstructured":"Tesmer VM, Lennarz S, Mayer G, Tesmer JJ. Molecular mechanism for inhibition of G protein-coupled receptor kinase 2 by a selective RNA aptamer. Structure. 2012;20:1300\u20139.","journal-title":"Structure"},{"key":"1869_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2025.1675209","volume":"16","author":"SK Makkar","year":"2025","unstructured":"Makkar SK. Advances in RNA-based therapeutics: current breakthroughs, clinical translation, and future perspectives. Front Genet. 2025;16:1675209.","journal-title":"Front Genet"},{"key":"1869_CR112","doi-asserted-by":"crossref","unstructured":"Thal DM, Yeow RY, Schoenau C, Huber J, Tesmer JJ. Molecular mechanism of selectivity among G protein-coupled receptor kinase 2 inhibitors. Mol Pharmacol. 2011;80:294\u2013303.","DOI":"10.1124\/mol.111.071522"},{"key":"1869_CR113","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1021\/jm9017515","volume":"53","author":"JJ Tesmer","year":"2010","unstructured":"Tesmer JJ, Tesmer VM, Lodowski DT, Steinhagen H, Huber J. Structure of human G protein-coupled receptor kinase 2 in complex with the kinase inhibitor balanol. J Med Chem. 2010;53:1867\u201370.","journal-title":"J Med Chem"},{"key":"1869_CR114","doi-asserted-by":"crossref","unstructured":"Yu Q, Gratzke C, Wang Y, Herlemann A, Strittmatter F, Rutz B, et al. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2\/3, CMPD101. Eur J Pharmacol. 2018;831:9\u201319.","DOI":"10.1016\/j.ejphar.2018.04.022"},{"key":"1869_CR115","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1021\/acs.jmedchem.7b00443","volume":"60","author":"T Okawa","year":"2017","unstructured":"Okawa T, Aramaki Y, Yamamoto M, Kobayashi T, Fukumoto S, Toyoda Y, et al. Design, synthesis, and evaluation of the highly selective and potent G-protein-coupled receptor kinase 2 (GRK2) inhibitor for the potential treatment of heart failure. J Med Chem. 2017;60:6942\u201390.","journal-title":"J Med Chem"},{"key":"1869_CR116","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1021\/acs.jmedchem.5b02000","volume":"59","author":"HV Waldschmidt","year":"2016","unstructured":"Waldschmidt HV, Homan KT, Cruz-Rodr\u00edguez O, Cato MC, Waninger-Saroni J, Larimore KM, et al. Structure-based design, synthesis, and biological evaluation of highly selective and potent G protein-coupled receptor kinase 2 inhibitors. J Med Chem. 2016;59:3793\u2013807.","journal-title":"J Med Chem"},{"key":"1869_CR117","doi-asserted-by":"crossref","unstructured":"Homan KT, Wu E, Wilson MW, Singh P, Larsen SD, Tesmer JJ. Structural and functional analysis of G protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. Mol Pharmacol. 2014;85:237\u201348.","DOI":"10.1124\/mol.113.089631"},{"key":"1869_CR118","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1021\/cb3003013","volume":"7","author":"DM Thal","year":"2012","unstructured":"Thal DM, Homan KT, Chen J, Wu EK, Hinkle PM, Huang ZM, et al. Paroxetine is a direct inhibitor of G protein-coupled receptor kinase 2 and increases myocardial contractility. ACS Chem Biol. 2012;7:1830\u20139.","journal-title":"ACS Chem Biol"},{"key":"1869_CR119","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1021\/acs.jmedchem.7b00112","volume":"60","author":"HV Waldschmidt","year":"2017","unstructured":"Waldschmidt HV, Homan KT, Cato MC, Cruz-Rodr\u00edguez O, Cannavo A, Wilson MW, et al. Structure-based design of highly selective and potent G protein-coupled receptor kinase 2 inhibitors based on paroxetine. J Med Chem. 2017;60:3052\u201369.","journal-title":"J Med Chem"},{"key":"1869_CR120","doi-asserted-by":"crossref","unstructured":"Bouley RA, Weinberg ZY, Waldschmidt HV, Yen YC, Larsen SD, Puthenveedu MA, et al. A new paroxetine-based GRK2 inhibitor reduces internalization of the \u03bc-opioid receptor. Mol Pharmacol. 2020;97:392\u2013401.","DOI":"10.1124\/mol.119.118661"},{"key":"1869_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1032497","volume":"13","author":"M Thapaliya","year":"2022","unstructured":"Thapaliya M, Amponnawarat A, Tesmer JJG, Ali H. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2. Front Immunol. 2022;13:1032497.","journal-title":"Front Immunol"},{"key":"1869_CR122","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016364","volume":"10","author":"X Sun","year":"2021","unstructured":"Sun X, Zhou M, Wen G, Huang Y, Wu J, Peng L, et al. Paroxetine attenuates cardiac hypertrophy via blocking GRK2 and ADRB1 interaction in hypertension. J Am Heart Assoc. 2021;10:e016364.","journal-title":"J Am Heart Assoc"},{"key":"1869_CR123","doi-asserted-by":"publisher","first-page":"277ra31","DOI":"10.1126\/scitranslmed.aaa0154","volume":"7","author":"SM Schumacher","year":"2015","unstructured":"Schumacher SM, Gao E, Zhu W, Chen X, Chuprun JK, Feldman AM, et al. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction. Sci Transl Med. 2015;7:277ra31.","journal-title":"Sci Transl Med"},{"key":"1869_CR124","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jacbts.2024.10.008","volume":"10","author":"R Roy","year":"2025","unstructured":"Roy R, Schumacher SM, Murphy HC, Grondolsky J, Rosales TO, Chuprun JK, et al. Therapeutic efficacy of a novel pharmacologic GRK2 inhibitor in multiple animal models of heart failure. JACC Basic Transl Sci. 2025;10:202\u201317.","journal-title":"JACC Basic Transl Sci"},{"key":"1869_CR125","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau8491","volume":"13","author":"EL Carlson","year":"2021","unstructured":"Carlson EL, Karuppagounder V, Pinamont WJ, Yoshioka NK, Ahmad A, Schott EM, et al. Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis. Sci Transl Med. 2021;13:eaau8491.","journal-title":"Sci Transl Med"},{"key":"1869_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113997","volume":"157","author":"J Tao","year":"2023","unstructured":"Tao J, Jiang C, Guo P, Chen H, Zhu Z, Su T, et al. A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation. Biomed Pharmacother. 2023;157:113997.","journal-title":"Biomed Pharmacother"},{"key":"1869_CR127","doi-asserted-by":"publisher","first-page":"17270","DOI":"10.3390\/ijms242417270","volume":"24","author":"AS Alonazi","year":"2023","unstructured":"Alonazi AS, Bin Dayel AF, Albuaijan DA, Bin Osfur AS, Hakami FM, Alzayed SS, et al. Cardioprotective effects of the GRK2 inhibitor paroxetine on isoproterenol-induced cardiac remodeling by modulating NF-\u03baB mediated prohypertrophic and profibrotic gene expression. Int J Mol Sci. 2023;24:17270.","journal-title":"Int J Mol Sci"},{"key":"1869_CR128","doi-asserted-by":"publisher","first-page":"11925","DOI":"10.2147\/DDDT.S572677","volume":"19","author":"KM Aldossary","year":"2025","unstructured":"Aldossary KM, Abdallah MS, Mosalam EM, Kamal N, Saif DS, Elsayed SA, et al. Efficacy of paroxetine as an adjuvant therapy in rheumatoid arthritis patients: a randomized controlled study. Drug Des Devel Ther. 2025;19:11925\u201339.","journal-title":"Drug Des Devel Ther"},{"key":"1869_CR129","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.3390\/ijms22041662","volume":"22","author":"M Kowalska","year":"2021","unstructured":"Kowalska M, Nowaczyk J, Fija\u0142kowski \u0141, Nowaczyk A. Paroxetine-overview of the molecular mechanisms of action. Int J Mol Sci. 2021;22:1662.","journal-title":"Int J Mol Sci"},{"key":"1869_CR130","doi-asserted-by":"crossref","unstructured":"Chen J, Wang Y, Wu H, Yan S, Chang Y, Wei W. A modified compound from paeoniflorin, CP-25, suppressed immune responses and synovium inflammation in collagen-induced arthritis mice. Front Pharmacol. 2018;9:563.","DOI":"10.3389\/fphar.2018.00563"},{"key":"1869_CR131","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.apsb.2021.01.015","volume":"11","author":"C Han","year":"2021","unstructured":"Han C, Li Y, Zhang Y, Wang Y, Cui D, Luo T, et al. Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. Acta Pharm Sin B. 2021;11:1835\u201352.","journal-title":"Acta Pharm Sin B"},{"key":"1869_CR132","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.7150\/ijbs.100176","volume":"21","author":"D Han","year":"2025","unstructured":"Han D, Sun H, Zhang R, Ge H, Guo P, Chu R, et al. Inhibition of GRK2-PDE4D axis suppresses fibroblast-like synoviocytes hyperplasia and alleviates experimental arthritis. Int J Biol Sci. 2025;21:1513\u201329.","journal-title":"Int J Biol Sci"},{"key":"1869_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112557","volume":"138","author":"D Han","year":"2024","unstructured":"Han D, Jiang C, Xu H, Chu R, Zhang R, Fang R, et al. Inhibition of GRK2 ameliorates the pristane-induced mouse SLE model by suppressing plasma cells differentiation. Int Immunopharmacol. 2024;138:112557.","journal-title":"Int Immunopharmacol"},{"key":"1869_CR134","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10565-024-09940-y","volume":"40","author":"Q Wang","year":"2024","unstructured":"Wang Q, Li M, Duan F, Xiao K, Sun QQ, Cheng JR, et al. GRK2 mediates cisplatin-induced acute liver injury via the modulation of NOX4. Cell Biol Toxicol. 2024;40:98.","journal-title":"Cell Biol Toxicol"},{"key":"1869_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106199","volume":"80","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang P, Liu Q, Zhang Q, Gu F, Xu S, et al. Alleviating effect of paeoniflorin-6\u2019-O-benzene sulfonate in antigen-induced experimental Sj\u00f6gren\u2019s syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK\/p38 signaling pathway. Int Immunopharmacol. 2020;80:106199.","journal-title":"Int Immunopharmacol"},{"key":"1869_CR136","doi-asserted-by":"crossref","unstructured":"Cheng J, Jiang X, Deng Q, Ni L, Lin W, Cao W, et al. Inhibition of GRK2 mitigates renal fibrosis via oxidative stress pathway. Eur J Pharmacol. 2025;1003:177887.","DOI":"10.1016\/j.ejphar.2025.177887"},{"key":"1869_CR137","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1097\/CM9.0000000000003165","volume":"138","author":"T Liu","year":"2025","unstructured":"Liu T, Jin C, Sun J, Zhu L, Wang C, Xiao F, et al. Paroxetine alleviates dendritic cell and T lymphocyte activation via GRK2-mediated PI3K-AKT signaling in rheumatoid arthritis. Chin Med J. 2025;138:441\u201351.","journal-title":"Chin Med J"},{"key":"1869_CR138","doi-asserted-by":"publisher","first-page":"16785","DOI":"10.1074\/jbc.M601327200","volume":"281","author":"DT Lodowski","year":"2006","unstructured":"Lodowski DT, Tesmer VM, Benovic JL, Tesmer JJ. The structure of G protein-coupled receptor kinase (GRK)-6 defines a second lineage of GRKs. J Biol Chem. 2006;281:16785\u201393.","journal-title":"J Biol Chem"},{"key":"1869_CR139","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrd.2016.199","volume":"16","author":"J Zhou","year":"2017","unstructured":"Zhou J, Rossi J. Aptamers as targeted therapeutics: current potential and challenges. Nat Rev Drug Discov. 2017;16:181\u2013202.","journal-title":"Nat Rev Drug Discov"},{"key":"1869_CR140","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1021\/jm201265f","volume":"55","author":"BW Jester","year":"2012","unstructured":"Jester BW, Gaj A, Shomin CD, Cox KJ, Ghosh I. Testing the promiscuity of commercial kinase inhibitors against the AGC kinase group using a split-luciferase screen. J Med Chem. 2012;55:1526\u201337.","journal-title":"J Med Chem"},{"key":"1869_CR141","doi-asserted-by":"crossref","unstructured":"Guo P, Wang R, Lu M, Wang M, Chu R, Hu S, et al. Paeoniflorin derivative ameliorates methotrexate resistance in treating rheumatoid arthritis through targeting GRK2-A2AAR axis. Phytomedicine. 2026;150:157731.","DOI":"10.1016\/j.phymed.2025.157731"},{"key":"1869_CR142","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.biopha.2018.12.040","volume":"110","author":"X Yang","year":"2019","unstructured":"Yang X, Zhao Y, Jia X, Wang C, Wu Y, Zhang L, et al. CP-25 combined with MTX\/ LEF ameliorates the progression of adjuvant-induced arthritis by the inhibition on GRK2 translocation. Biomed Pharmacother. 2019;110:834\u201343.","journal-title":"Biomed Pharmacother"},{"key":"1869_CR143","doi-asserted-by":"crossref","unstructured":"Fang RH, Zhou ZW, Chu R, Guan QY, He F, Ge ML, et al. G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sj\u00f6gren\u2019s syndrome. Acta Pharmacol Sin. 2024;45:2611\u201324.","DOI":"10.1038\/s41401-024-01350-4"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01869-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01869-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01869-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:03:40Z","timestamp":1789635820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01869-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,7]]},"references-count":143,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01869-8","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,7]]},"assertion":[{"value":"30 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The corresponding author Wei\u00a0Wei is a member of the Editorial Board of the journal Acta Pharmacologica Sinica, but he has not been involved in the peer-review or decision-making process for this manuscript. Other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}